Dr. Harry P. Erba, MD
Medical Oncology (Medical Oncology Physician)
1500 East Medical Center Dr, B1 Floor Cancer & Geriatrics Ctr Recp B
Ann Arbor, MI 48109
- Medicare participating
At a glance
- Medical school
- Stanford University School of Medicine (1988)
- Years since graduation
- 38
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 134
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1988Medical school: Stanford University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Medical Oncology Physician primary
MI license 4301068402 -
Hematology (Internal Medicine) Physician
MI license 4301068402 -
Internal Medicine Physician
MI license 4301068402
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Duke University Hospital Durham, NC
- Duke Regional Hospital Durham, NC
Medical groups
- Duke Health Integrated Practice, Inc (3,185 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 134
- Services billed
- 821
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 283 | 39 |
| Established patient office or other outpatient visit, 30-39 minutes | 271 | 93 |
| Hospital discharge day management, 30 minutes or less | 24 | 23 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 20 | 20 |
| Established patient office or other outpatient visit, 40-54 minutes | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Acyclovir Other prescribers in Ann Arbor, MI | 130 |
| Venclexta (venetoclax) | 101 |
| Jakafi (ruxolitinib phosphate) | 54 |
| Potassium Chloride Other prescribers in Ann Arbor, MI | 45 |
| Sulfamethoxazole-Trimethoprim (sulfamethoxazole/trimethoprim) Other prescribers in Ann Arbor, MI | 43 |
| Prednisone Other prescribers in Ann Arbor, MI | 34 |
| Hydroxyurea Other prescribers in Ann Arbor, MI | 33 |
| Pantoprazole Sodium Other prescribers in Ann Arbor, MI | 32 |
| Tibsovo (ivosidenib) | 32 |
| Imatinib Mesylate | 30 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 7 companies reported 138 payments worth $187,022 in total to this clinician.
| Incyte Corporation | $78,042 |
|---|---|
| Daiichi Sankyo Inc. | $38,680 |
| Servier Pharmaceuticals LLC | $34,129 |
| Syndax Pharmaceuticals, Inc. | $20,769 |
| Taiho Oncology, Inc. | $6,472 |
| Sumitomo Pharma America, Inc. | $6,020 |
| Rigel Pharmaceuticals, Inc. | $2,911 |
| Compensation for services other than consulting (speaking, faculty) | $81,751 |
|---|---|
| Consulting Fee | $53,448 |
| Speaking at a medical education program | $24,140 |
| Travel and Lodging | $21,350 |
| Food and Beverage | $3,594 |
| Honoraria | $2,740 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Daiichi Sankyo Inc. Nov 19, 2025 | Consulting Fee Vanflyta · ONCOLOGY | $8,061 |
| Incyte Corporation Oct 9, 2025 | Consulting Fee Jakafi · Hematology/Oncology | $7,878 |
| Syndax Pharmaceuticals, Inc. Nov 7, 2025 | Compensation for services other than consulting (speaking, faculty) | $7,200 |
| Servier Pharmaceuticals LLC Apr 25, 2025 | Speaking at a medical education program Tibsovo · Oncology | $6,460 |
| Servier Pharmaceuticals LLC Jul 25, 2025 | Speaking at a medical education program Tibsovo · Oncology | $6,460 |
| Servier Pharmaceuticals LLC Oct 23, 2025 | Speaking at a medical education program Tibsovo · Oncology | $6,460 |
| Syndax Pharmaceuticals, Inc. Mar 14, 2025 | Compensation for services other than consulting (speaking, faculty) | $5,600 |
| Syndax Pharmaceuticals, Inc. Jun 26, 2025 | Compensation for services other than consulting (speaking, faculty) | $5,600 |
| Incyte Corporation Jun 11, 2025 | Compensation for services other than consulting (speaking, faculty) Jakafi · Hematology/Oncology | $5,480 |
| Incyte Corporation May 13, 2025 | Compensation for services other than consulting (speaking, faculty) Jakafi · Hematology/Oncology | $5,480 |
All 112 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Daiichi Sankyo Inc. Dec 23, 2025 | Consulting Fee Vanflyta · ONCOLOGY | $3,430 |
| Daiichi Sankyo Inc. Dec 23, 2025 | Consulting Fee Vanflyta · ONCOLOGY | $1,290 |
| Daiichi Sankyo Inc. Dec 15, 2025 | Compensation for services other than consulting (speaking, faculty) Vanflyta · ONCOLOGY | $1,029 |
| Incyte Corporation Dec 3, 2025 | Compensation for services other than consulting (speaking, faculty) Jakafi · Hematology/Oncology | $5,480 |
| Daiichi Sankyo Inc. Nov 19, 2025 | Consulting Fee Vanflyta · ONCOLOGY | $8,061 |
| Daiichi Sankyo Inc. Nov 19, 2025 | Compensation for services other than consulting (speaking, faculty) Vanflyta · ONCOLOGY · in-kind | $64.00 |
| Taiho Oncology, Inc. Nov 12, 2025 | Consulting Fee INQOVI · Oncology | $5,460 |
| Taiho Oncology, Inc. Nov 12, 2025 | Travel and Lodging INQOVI · Oncology · travel to Dallas, TX | $947 |
| Incyte Corporation Nov 11, 2025 | Compensation for services other than consulting (speaking, faculty) Jakafi · Hematology/Oncology | $2,055 |
| Incyte Corporation Nov 11, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Chicago, IL | $750 |
| Incyte Corporation Nov 11, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Chicago, IL | $419 |
| Incyte Corporation Nov 11, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Chicago, IL | $298 |
| Incyte Corporation Nov 11, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Chicago, IL | $28.42 |
| Syndax Pharmaceuticals, Inc. Nov 7, 2025 | Compensation for services other than consulting (speaking, faculty) | $7,200 |
| Daiichi Sankyo Inc. Nov 6, 2025 | Travel and Lodging Vanflyta · ONCOLOGY · travel to ORLANDO, FL · in-kind | $618 |
| Daiichi Sankyo Inc. Nov 6, 2025 | Travel and Lodging Vanflyta · ONCOLOGY · travel to ORLANDO, FL · in-kind | $196 |
| Daiichi Sankyo Inc. Nov 6, 2025 | Travel and Lodging Vanflyta · ONCOLOGY · travel to ORLANDO, FL · in-kind | $189 |
| Servier Pharmaceuticals LLC Oct 23, 2025 | Speaking at a medical education program Tibsovo · Oncology | $6,460 |
| Servier Pharmaceuticals LLC Oct 23, 2025 | Travel and Lodging Tibsovo · Oncology · travel to New York, NY · in-kind | $399 |
| Incyte Corporation Oct 14, 2025 | Compensation for services other than consulting (speaking, faculty) Jakafi · Hematology/Oncology | $4,110 |
| Incyte Corporation Oct 14, 2025 | Compensation for services other than consulting (speaking, faculty) Jakafi · Hematology/Oncology | $4,110 |
| Servier Pharmaceuticals LLC Oct 14, 2025 | Travel and Lodging Tibsovo · Oncology · travel to New York, NY · in-kind | $438 |
| Servier Pharmaceuticals LLC Oct 14, 2025 | Travel and Lodging Tibsovo · Oncology · travel to New York, NY · in-kind | $292 |
| Incyte Corporation Oct 9, 2025 | Consulting Fee Jakafi · Hematology/Oncology | $7,878 |
| Incyte Corporation Oct 8, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Jacksonville, NC | $1,030 |
| Incyte Corporation Oct 7, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Suffolk, VA | $1,202 |
| Incyte Corporation Oct 1, 2025 | Compensation for services other than consulting (speaking, faculty) Jakafi · Hematology/Oncology | $5,480 |
| Incyte Corporation Sep 23, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Orland Park, IL | $893 |
| Incyte Corporation Sep 23, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Orland Park, IL | $387 |
| Incyte Corporation Sep 23, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Orland Park, IL | $263 |
| Incyte Corporation Sep 23, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Orland Park, IL | $56.00 |
| Incyte Corporation Sep 23, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Orland Park, IL | $28.00 |
| Incyte Corporation Sep 17, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Scottsdale, AZ | $586 |
| Incyte Corporation Sep 17, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Scottsdale, AZ | $64.00 |
| Incyte Corporation Sep 17, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Scottsdale, AZ | $28.00 |
| Incyte Corporation Sep 16, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Scottsdale, AZ | $576 |
| Incyte Corporation Sep 16, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Scottsdale, AZ | $526 |
| Incyte Corporation Sep 15, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Scottsdale, AZ | $249 |
| Rigel Pharmaceuticals, Inc. Sep 13, 2025 | Honoraria Rezlidhia · Acute Myeloid Leukemia | $2,740 |
| Daiichi Sankyo Inc. Sep 10, 2025 | Consulting Fee Vanflyta · ONCOLOGY | $4,116 |
| Incyte Corporation Sep 2, 2025 | Compensation for services other than consulting (speaking, faculty) Jakafi · Hematology/Oncology | $5,480 |
| Incyte Corporation Sep 2, 2025 | Compensation for services other than consulting (speaking, faculty) Jakafi · Hematology/Oncology | $2,055 |
| Incyte Corporation Aug 27, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Morristown, NJ | $687 |
| Incyte Corporation Aug 27, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Morristown, NJ | $302 |
| Incyte Corporation Aug 27, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Morristown, NJ | $32.00 |
| Incyte Corporation Aug 27, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Morristown, NJ | $28.42 |
| Sumitomo Pharma America, Inc. Aug 14, 2025 | Consulting Fee | $2,580 |
| Incyte Corporation Aug 12, 2025 | Compensation for services other than consulting (speaking, faculty) Jakafi · Hematology/Oncology | $2,055 |
| Daiichi Sankyo Inc. Aug 8, 2025 | Compensation for services other than consulting (speaking, faculty) Vanflyta · ONCOLOGY | $968 |
| Servier Pharmaceuticals LLC Jul 25, 2025 | Speaking at a medical education program Tibsovo · Oncology | $6,460 |
| Servier Pharmaceuticals LLC Jul 18, 2025 | Speaking at a medical education program Tibsovo · Oncology | $1,020 |
| Servier Pharmaceuticals LLC Jul 16, 2025 | Travel and Lodging Tibsovo · Oncology · travel to Lahaina, HI · in-kind | $1,177 |
| Servier Pharmaceuticals LLC Jul 16, 2025 | Travel and Lodging Tibsovo · Oncology · travel to Lahaina, HI · in-kind | $779 |
| Daiichi Sankyo Inc. Jul 2, 2025 | Consulting Fee Vanflyta · ONCOLOGY | $1,290 |
| Daiichi Sankyo Inc. Jun 30, 2025 | Compensation for services other than consulting (speaking, faculty) Vanflyta · ONCOLOGY | $968 |
| Daiichi Sankyo Inc. Jun 30, 2025 | Compensation for services other than consulting (speaking, faculty) Vanflyta · ONCOLOGY | $968 |
| Daiichi Sankyo Inc. Jun 30, 2025 | Compensation for services other than consulting (speaking, faculty) Vanflyta · ONCOLOGY | $968 |
| Syndax Pharmaceuticals, Inc. Jun 26, 2025 | Compensation for services other than consulting (speaking, faculty) | $5,600 |
| Syndax Pharmaceuticals, Inc. Jun 17, 2025 | Travel and Lodging travel to GREENVILLE, SC · in-kind | $1,355 |
| Incyte Corporation Jun 12, 2025 | Compensation for services other than consulting (speaking, faculty) Jakafi · Hematology/Oncology | $2,055 |
| Incyte Corporation Jun 11, 2025 | Compensation for services other than consulting (speaking, faculty) Jakafi · Hematology/Oncology | $5,480 |
| Daiichi Sankyo Inc. May 30, 2025 | Travel and Lodging Vanflyta · ONCOLOGY · travel to CHICAGO, IL · in-kind | $470 |
| Incyte Corporation May 27, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Chicago, IL | $442 |
| Incyte Corporation May 27, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Chicago, IL | $358 |
| Incyte Corporation May 27, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Chicago, IL | $185 |
| Incyte Corporation May 27, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Chicago, IL | $185 |
| Incyte Corporation May 27, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Chicago, IL | $56.00 |
| Incyte Corporation May 27, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Chicago, IL | $28.42 |
| Servier Pharmaceuticals LLC May 16, 2025 | Consulting Fee | $2,380 |
| Incyte Corporation May 13, 2025 | Compensation for services other than consulting (speaking, faculty) Jakafi · Hematology/Oncology | $5,480 |
| Daiichi Sankyo Inc. May 7, 2025 | Compensation for services other than consulting (speaking, faculty) Vanflyta · ONCOLOGY | $968 |
| Daiichi Sankyo Inc. May 7, 2025 | Compensation for services other than consulting (speaking, faculty) Vanflyta · ONCOLOGY | $968 |
| Incyte Corporation May 6, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Caledonia, MI | $673 |
| Incyte Corporation May 6, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Caledonia, MI | $515 |
| Incyte Corporation May 6, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Caledonia, MI | $188 |
| Incyte Corporation May 6, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Caledonia, MI | $42.00 |
| Incyte Corporation May 6, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Caledonia, MI | $28.42 |
| Incyte Corporation Apr 29, 2025 | Compensation for services other than consulting (speaking, faculty) Jakafi · Hematology/Oncology | $1,370 |
| Servier Pharmaceuticals LLC Apr 25, 2025 | Speaking at a medical education program Tibsovo · Oncology | $6,460 |
| Servier Pharmaceuticals LLC Apr 25, 2025 | Speaking at a medical education program Tibsovo · Oncology | $3,740 |
| Daiichi Sankyo Inc. Apr 16, 2025 | Consulting Fee Vanflyta · ONCOLOGY | $2,580 |
| Incyte Corporation Apr 15, 2025 | Compensation for services other than consulting (speaking, faculty) Jakafi · Hematology/Oncology | $4,453 |
| Incyte Corporation Apr 11, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Brooklyn, NY | $527 |
| Incyte Corporation Apr 11, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Brooklyn, NY | $464 |
| Incyte Corporation Apr 11, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Brooklyn, NY | $325 |
| Incyte Corporation Apr 11, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Brooklyn, NY | $245 |
| Incyte Corporation Apr 11, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Brooklyn, NY | $56.00 |
| Incyte Corporation Apr 11, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Brooklyn, NY | $28.42 |
| Incyte Corporation Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) Jakafi · Hematology/Oncology | $343 |
| Syndax Pharmaceuticals, Inc. Mar 28, 2025 | Travel and Lodging travel to CHARLESTON, SC | $78.57 |
| Syndax Pharmaceuticals, Inc. Mar 28, 2025 | Travel and Lodging travel to CHARLESTON, SC | $32.00 |
| Syndax Pharmaceuticals, Inc. Mar 28, 2025 | Travel and Lodging travel to CHARLESTON, SC | $28.42 |
| Incyte Corporation Mar 26, 2025 | Compensation for services other than consulting (speaking, faculty) Jakafi · Hematology/Oncology | $5,480 |
| Daiichi Sankyo Inc. Mar 26, 2025 | Consulting Fee Vanflyta · ONCOLOGY | $1,290 |
| Incyte Corporation Mar 22, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Atlanta, GA | $399 |
| Incyte Corporation Mar 22, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Atlanta, GA | $280 |
| Incyte Corporation Mar 22, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Atlanta, GA | $170 |
| Incyte Corporation Mar 22, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Atlanta, GA | $155 |
| Incyte Corporation Mar 22, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Atlanta, GA | $32.00 |
| Incyte Corporation Mar 22, 2025 | Travel and Lodging Jakafi · Hematology/Oncology · travel to Atlanta, GA | $28.42 |
| Servier Pharmaceuticals LLC Mar 20, 2025 | Consulting Fee Tibsovo · Oncology | $2,720 |
| Daiichi Sankyo Inc. Mar 19, 2025 | Consulting Fee Vanflyta · ONCOLOGY | $3,870 |
| Syndax Pharmaceuticals, Inc. Mar 14, 2025 | Compensation for services other than consulting (speaking, faculty) | $5,600 |
| Syndax Pharmaceuticals, Inc. Mar 5, 2025 | Travel and Lodging travel to CHARLESTON, SC · in-kind | $20.11 |
| Syndax Pharmaceuticals, Inc. Mar 4, 2025 | Travel and Lodging travel to CHARLESTON, SC · in-kind | $336 |
| Syndax Pharmaceuticals, Inc. Mar 4, 2025 | Travel and Lodging travel to CHARLESTON, SC · in-kind | $126 |
| Syndax Pharmaceuticals, Inc. Mar 4, 2025 | Travel and Lodging travel to CHARLESTON, SC · in-kind | $22.69 |
| Daiichi Sankyo Inc. Feb 28, 2025 | Compensation for services other than consulting (speaking, faculty) Vanflyta · ONCOLOGY | $968 |
| Daiichi Sankyo Inc. Feb 6, 2025 | Consulting Fee Vanflyta · ONCOLOGY | $645 |
| Sumitomo Pharma America, Inc. Jan 23, 2025 | Consulting Fee | $3,440 |
| Daiichi Sankyo Inc. Jan 23, 2025 | Consulting Fee Vanflyta · ONCOLOGY | $1,774 |
| Daiichi Sankyo Inc. Jan 23, 2025 | Consulting Fee Vanflyta · ONCOLOGY | $645 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 6 industry-funded studies in 2025, from 6 companies. The companies reported $279,572 in research payments for these studies, mostly to the institutions running them.
- A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Sumitomo Pharma America, Inc. · Recruiting · NCT04988555 - Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Daiichi Sankyo Inc. · Active, not recruiting · NCT06578247 - Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
E.r. Squibb & Sons, L.l.c. · Recruiting · NCT06577441 - A Multi-phase, Dose-Escalation Followed by an Open-label, Randomized, Crossover Study of Oral ASTX030 (Cedazuridine and Azacitidine Given in Combination) Versus Subcutaneous Azacitidine in Subjects With Myelodysplasti…
Taiho Oncology, Inc. - A Phase 2a/2b, Open-label, Proof of Concept (Phase 2a) and Open-label (Phase 2b), Multicenter, Efficacy, and Safety Study of AG-946 in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes
Agios Pharmaceuticals, Inc. - A Phase II Multi-center, Single Arm, Safety and Efficacy Study of MBG453 in Combination With Azacitidine and Venetoclax for the Treatment of Acute Myeloid Leukemia (AML) in Adult Patients Unfit for Chemotherapy
Novartis Pharmaceuticals Corporation
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.